Skip to Content

MYLAN 233 (Efavirenz 600 mg)

Pill with imprint MYLAN 233 is Yellow, Capsule-shape and has been identified as Efavirenz 600 mg. It is supplied by Mylan Pharmaceuticals Inc..

Efavirenz is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class NNRTIs. There is positive evidence of human fetal risk during pregnancy. Efavirenz 600 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 233

Efavirenz 600 mg MYLAN 233

Efavirenz

Imprint
MYLAN 233
Strength
600 mg
Color
Yellow
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
NNRTIs
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-2233
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferric oxide red, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.